Product
Intensive phosphate
1 clinical trial
3 indications
Indication
Kidney FailureIndication
ChronicIndication
HyperphosphatemiaClinical trial
An Investigator-initiated, International, Multi-centre, Prospective, Randomized, Open-label, Parallel-group, Superiority, and Pragmatic Large Simple Trial (LST) to Determine Whether the Currently Recommended Strategy of Intensive Reduction of Serum Phosphate Concentration Towards the Normal Level Results in Significant Patient-centred Benefits in End-stage Kidney Disease (ESKD) Patients Receiving Dialysis.Status: Recruiting, Estimated PCD: 2027-12-31